PurchasingPolicy.orgPURCHASINGPOLICYBETA
← Back to Influence Map
Entity DossierOrganization

REGENXBIO

MD · US

Develop innovative therapies to treat patients with rare or otherwise debilitating disease

Tracked direct giving

$0

Tracked donations to candidate

$0

LDA reported lobbying spend

$15,000

Connections

2

Lobbying Activity Detail

Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.

Top Lobbying Issues

HCRHealth Issues
$788K
TAXTaxation/Internal Revenue Code
$668K
TRDTrade
$438K
CPTCopyright/Patent/Trademark
$438K
IMMImmigration
$438K
MMMMedicare/Medicaid
$230K
PHAPharmacy
$230K

Lobbying Firms Retained

REGENXBIO$438K
KNIGHT CAPITOL CONSULTANTS$245K
THEGROUP DC, LLC$120K

Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.

Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome

Click a node to see details

Double-click to expand its connections

Relationships

TypeConnected ToDetailsSource
Employed byKNIGHT CAPITOL CONSULTANTSHired KNIGHT CAPITOL CONSULTANTS to lobby on PharmaceuticalsSource
Employed byTHEGROUP DC, LLCHired THEGROUP DC, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2026)Source